- Email: [email protected]
Short-, medium-, and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: 1000 patients
MEETING COMMITTEE In advance of the upcoming annual meeting of the Society of Interventional Radiology in Washington, DC, the program committee wishes to highlight the scientific abstracts that will be presented. Abstracts were chosen using blinded review. Authors are congratulated for their contributions. The abstracts of the year, distinguished abstracts, and featured abstracts are designated as such. Daniel Y. Sze, MD, FSIR Chair, 2017 Annual Meeting Scientific Program
ABSTRACTS OF THE YEAR
Plenary: Wednesday Plenary Wednesday, March 8, 2017 10:30 AM – 12:00 PM Ballroom 10:30 AM
Abstract No. 1
’ ABSTRACT OF THE YEAR Short-, medium-, and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: 1000 patients J. Pisco1, T. Bilhim1, M. Ribeiro1, L. Fernandes2, N. Costa3, A. Oliveira1; 1N/A, Lisbon, Portugal; 2N/A, Lisboa, Portugal; 3Hospital Saint Louis, Lisboa, Portugal ASM Abstracts Supplement Disclaimer Notice SIR assumes no legal liability or responsibility for the completeness, accuracy, and correctness of the information presented in the abstracts. Abstracts will be published in the Annual Meeting Supplement to the Journal of Vascular and Interventional Radiology as submitted by the authors, except for minor stylistic adjustments to ensure consistency of format and adherence to Supplement style. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources. Because of the differences between in vitro and in vivo systems and between laboratory animal models and clinical data in humans, in vitro and animal data may not necessarily correlate with clinical results. *An underline under an author’s name designates the abstract presenter. †
N/A in the author affiliation area indicates that no affiliation was available at press time. & SIR, 2017
Purpose: To confirm that prostatic artery embolization (PAE) is safe and effective treatment with short, medium and long-term outcome in symptomatic benign prostatic hyperplasia patient (BPH) with moderate to severe lower urinary tract symptoms (LUTS). Materials: Between March 2007 and March 2016, 1000 patients underwent PAE as an outpatient procedure in a single cohort center. All patients were evaluated at 1, 3 and 6 months (short term), 807 patients were evaluated at 6 months and every 6 months, medium term between 1 and 3 years and 406 patients were evaluated at long term every year after 3 years of PAE. The prostate was larger than 100 cm3 in 210 patients and 112 patients were in acute urinary retention (AUR) with an indwelling catheter. Results: Mean patients age was 67.3 years ± 8.2 (range 40-89 y). There were 17 (1.7%) technical failures. Bilateral PAE was performed in 910 (91%) patients and unilateral in 90 (9%) patients. There was a statistically significant (Po 0.001) change from baseline to observed value in all evaluated parameters: IPSS, QoL, IIEF, PSA, prostate volume, Qmax and PVR. The cumulative clinical success rates at short-, medium-, and long-term follow up were 89% (95% CI, 79.1%–93.2%), 82.2% (95% CI, 72.4%–89.3), and 78.1% (95% CI, 69.2–83.5%) From the 112 patients in AUR, 106 (94.6%) had the catheter removed between 2 days and 3 months; at medium and long term 95 (84,8%) and 89 (78.5%) of the patients respectively did not have any recurrence.The cumulative clinical success rates of the 210 patients with prostate larger then 100 were 84% (95% CI 81.2%–91.2%) at short term and 76.2% (95% CI, 77.1%– 83%) at medium and long term.There were two major complications, a bladder ischemia and a perineal pain for 3 months without sequelae. There was not any sexual dysfunction or urinary dysfunction. Conclusions: PAE is an effective and safe out procedure in symptomatic BPH with moderate to severe LUTS and good results at short, medium and long term. The best results were obtained in patients with AUR.
Abstracts Chosen by the Annual Scientific Meeting Committee
ABSTRACTS CHOSEN BY THE ANNUAL SCIENTIFIC
ABSTRACTS OF THE YEAR
Plenary: Wednesday Plenary Wednesday, March 8, 2017 10:30 AM – 12:00 PM Ballroom 10:30 AM
Abstract No. 1
’ ABSTRACT OF THE YEAR Short-, medium-, and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: 1000 patients J. Pisco1, T. Bilhim1, M. Ribeiro1, L. Fernandes2, N. Costa3, A. Oliveira1; 1N/A, Lisbon, Portugal; 2N/A, Lisboa, Portugal; 3Hospital Saint Louis, Lisboa, Portugal ASM Abstracts Supplement Disclaimer Notice SIR assumes no legal liability or responsibility for the completeness, accuracy, and correctness of the information presented in the abstracts. Abstracts will be published in the Annual Meeting Supplement to the Journal of Vascular and Interventional Radiology as submitted by the authors, except for minor stylistic adjustments to ensure consistency of format and adherence to Supplement style. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources. Because of the differences between in vitro and in vivo systems and between laboratory animal models and clinical data in humans, in vitro and animal data may not necessarily correlate with clinical results. *An underline under an author’s name designates the abstract presenter. †
N/A in the author affiliation area indicates that no affiliation was available at press time. & SIR, 2017
Purpose: To confirm that prostatic artery embolization (PAE) is safe and effective treatment with short, medium and long-term outcome in symptomatic benign prostatic hyperplasia patient (BPH) with moderate to severe lower urinary tract symptoms (LUTS). Materials: Between March 2007 and March 2016, 1000 patients underwent PAE as an outpatient procedure in a single cohort center. All patients were evaluated at 1, 3 and 6 months (short term), 807 patients were evaluated at 6 months and every 6 months, medium term between 1 and 3 years and 406 patients were evaluated at long term every year after 3 years of PAE. The prostate was larger than 100 cm3 in 210 patients and 112 patients were in acute urinary retention (AUR) with an indwelling catheter. Results: Mean patients age was 67.3 years ± 8.2 (range 40-89 y). There were 17 (1.7%) technical failures. Bilateral PAE was performed in 910 (91%) patients and unilateral in 90 (9%) patients. There was a statistically significant (Po 0.001) change from baseline to observed value in all evaluated parameters: IPSS, QoL, IIEF, PSA, prostate volume, Qmax and PVR. The cumulative clinical success rates at short-, medium-, and long-term follow up were 89% (95% CI, 79.1%–93.2%), 82.2% (95% CI, 72.4%–89.3), and 78.1% (95% CI, 69.2–83.5%) From the 112 patients in AUR, 106 (94.6%) had the catheter removed between 2 days and 3 months; at medium and long term 95 (84,8%) and 89 (78.5%) of the patients respectively did not have any recurrence.The cumulative clinical success rates of the 210 patients with prostate larger then 100 were 84% (95% CI 81.2%–91.2%) at short term and 76.2% (95% CI, 77.1%– 83%) at medium and long term.There were two major complications, a bladder ischemia and a perineal pain for 3 months without sequelae. There was not any sexual dysfunction or urinary dysfunction. Conclusions: PAE is an effective and safe out procedure in symptomatic BPH with moderate to severe LUTS and good results at short, medium and long term. The best results were obtained in patients with AUR.
Abstracts Chosen by the Annual Scientific Meeting Committee
ABSTRACTS CHOSEN BY THE ANNUAL SCIENTIFIC